rs35353912
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_004187.5(KDM5C):c.1794C>T(p.Pro598Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00306 in 1,210,529 control chromosomes in the GnomAD database, including 4 homozygotes. There are 1,171 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004187.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM5C | NM_004187.5 | c.1794C>T | p.Pro598Pro | synonymous_variant | 13/26 | ENST00000375401.8 | NP_004178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM5C | ENST00000375401.8 | c.1794C>T | p.Pro598Pro | synonymous_variant | 13/26 | 1 | NM_004187.5 | ENSP00000364550.4 |
Frequencies
GnomAD3 genomes AF: 0.00207 AC: 233AN: 112329Hom.: 0 Cov.: 23 AF XY: 0.00162 AC XY: 56AN XY: 34485
GnomAD3 exomes AF: 0.00179 AC: 329AN: 183514Hom.: 0 AF XY: 0.00184 AC XY: 125AN XY: 67942
GnomAD4 exome AF: 0.00316 AC: 3475AN: 1098148Hom.: 4 Cov.: 30 AF XY: 0.00307 AC XY: 1115AN XY: 363502
GnomAD4 genome AF: 0.00207 AC: 233AN: 112381Hom.: 0 Cov.: 23 AF XY: 0.00162 AC XY: 56AN XY: 34547
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 05, 2014 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 20, 2015 | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 13, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at